Kevin C. Tang, Director at HERON THERAPEUTICS, INC. /DE/ (HRTX), bought 285,714 shares at $17.50 ($5.0M) on 2019-10-04, disclosed to the SEC on 2019-10-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ODT | BUY | 2020-12-23 | $8.4M | — | Filing → |
| LJPC | BUY | 2020-08-14 | $3.2M | — | Filing → |
| LJPC | BUY | 2020-02-03 | $1.7M | — | Filing → |